181 related articles for article (PubMed ID: 37693264)
41. Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for Non-tumoral Cirrhotic Portal Vein Thrombosis Not Responding to Anticoagulation Therapy.
Mukund A; Marri UK; Jindal A; Choudhury A; Patidar Y; Sarin SK
Dig Dis Sci; 2023 Jul; 68(7):3174-3184. PubMed ID: 37169934
[TBL] [Abstract][Full Text] [Related]
42. Transjugular Intrahepatic Portosystemic Shunt Through the Strut of a Previously Placed Stent: Technical Feasibility and Long-Term Follow-Up Results.
Ahmed M; Keshava SN; Moses V; Chiramel GK; Mammen S; Eapen CE; Zachariah UG
Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1794-1798. PubMed ID: 30014251
[TBL] [Abstract][Full Text] [Related]
43. Technical and Medium-Term Clinical Outcomes of Transjugular Intrahepatic Portosystemic Shunt with Fluoroscopy and Additional Trans-abdominal Ultrasound Guidance.
Keshava SN; Moses V; Sharma A; Ahmed M; Narayanan S; Padmanabhan A; Goel A; Zachariah U; Eapen CE
Indian J Radiol Imaging; 2021 Oct; 31(4):858-866. PubMed ID: 35136497
[No Abstract] [Full Text] [Related]
44. Endovascular stenting of the inferior vena cava in a patient with Budd-Chiari syndrome and main hepatic vein thrombosis: a case report.
Yoon YI; Hwang S; Ko GY; Ha TY; Song GW; Jung DH; Lee YS; Lee SG
Korean J Hepatobiliary Pancreat Surg; 2015 Feb; 19(1):35-9. PubMed ID: 26155275
[TBL] [Abstract][Full Text] [Related]
45. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis.
Darwish Murad S; Valla DC; de Groen PC; Zeitoun G; Haagsma EB; Kuipers EJ; Janssen HL
Am J Gastroenterol; 2006 Jan; 101(1):83-90. PubMed ID: 16405538
[TBL] [Abstract][Full Text] [Related]
46. [Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome with extensive occlusion of the hepatic veins].
Wu XJ; Cao JM; Han JM; Li JS
Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1029-32. PubMed ID: 17074238
[TBL] [Abstract][Full Text] [Related]
47. Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosis.
Mahmoud AE; Helmy AS; Billingham L; Elias E
Eur J Gastroenterol Hepatol; 1997 May; 9(5):485-9. PubMed ID: 9187882
[TBL] [Abstract][Full Text] [Related]
48. Treatment of Budd-Chiari syndrome by side-to-side portacaval shunt: experimental and clinical results.
Orloff MJ; Johansen KH
Ann Surg; 1978 Oct; 188(4):494-512. PubMed ID: 697434
[TBL] [Abstract][Full Text] [Related]
49. Budd-Chiari syndrome: hepatic venous web outflow obstruction treated by percutaneous placement of hepatic vein stent.
Bozorgmanesh A; Selvam DA; Caridi JG
Semin Intervent Radiol; 2007 Mar; 24(1):100-5. PubMed ID: 21326746
[TBL] [Abstract][Full Text] [Related]
50. Acute Portal Vein Thrombosis, No Longer a Contraindication for Transjugular Intrahepatic Porto-Systemic Shunt (TIPS) Insertion.
Mammen S; Keshava SN; Kattiparambil S
J Clin Exp Hepatol; 2015 Sep; 5(3):259-61. PubMed ID: 26628844
[TBL] [Abstract][Full Text] [Related]
51. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.
Janssen HL; Meinardi JR; Vleggaar FP; van Uum SH; Haagsma EB; van Der Meer FJ; van Hattum J; Chamuleau RA; Adang RP; Vandenbroucke JP; van Hoek B; Rosendaal FR
Blood; 2000 Oct; 96(7):2364-8. PubMed ID: 11001884
[TBL] [Abstract][Full Text] [Related]
52. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.
Olliff SP
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1151-4. PubMed ID: 17033433
[TBL] [Abstract][Full Text] [Related]
53. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation.
Senzolo M; Tibbals J; Cholongitas E; Triantos CK; Burroughs AK; Patch D
Aliment Pharmacol Ther; 2006 Mar; 23(6):767-75. PubMed ID: 16556179
[TBL] [Abstract][Full Text] [Related]
54. Management of splanchnic vein thrombosis.
Elkrief L; Payancé A; Plessier A; d'Alteroche L; Ronot M; Paradis V; Valla D; Rautou PE
JHEP Rep; 2023 Apr; 5(4):100667. PubMed ID: 36941824
[TBL] [Abstract][Full Text] [Related]
55. PAI-1 4G-4G, MTHFR 677TT, V Leiden 506Q, and Prothrombin 20210A in Splanchnic Vein Thrombosis: Analysis of Individual Patient Data From Three Prospective Studies.
Pasta L; Pasta F; D'Amico M
J Clin Exp Hepatol; 2016 Mar; 6(1):10-4. PubMed ID: 27194890
[TBL] [Abstract][Full Text] [Related]
56. Pain Management of Budd Chiari Syndrome in the Primary Care Setting: A Case Study.
Murphy PZ; Thomas J; McClelland TP
Innov Pharm; 2021; 12(2):. PubMed ID: 34345504
[TBL] [Abstract][Full Text] [Related]
57. Spontaneous intrahepatic portosystemic shunt in Budd-Chiari syndrome.
Ding PX; Li Z; Han XW; Zhang WG; Zhou PL; Wang ZG
Ann Vasc Surg; 2014 Apr; 28(3):742.e1-4. PubMed ID: 24495329
[TBL] [Abstract][Full Text] [Related]
58. Comparison of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Cirrhosis With or Without Portal Vein Thrombosis: A Retrospective Study.
Wang HL; Lu WJ; Zhang YL; Nie CH; Zhou TY; Zhou GH; Zhu TY; Wang BQ; Chen SQ; Yu ZN; Jing L; Sun JH
Front Med (Lausanne); 2021; 8():737984. PubMed ID: 34671621
[No Abstract] [Full Text] [Related]
59. Acute Budd-Chiari syndrome with liver failure: the experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt.
Kavanagh PM; Roberts J; Gibney R; Malone D; Hegarty J; McCormick PA
J Gastroenterol Hepatol; 2004 Oct; 19(10):1135-9. PubMed ID: 15377290
[TBL] [Abstract][Full Text] [Related]
60. Transjugular intrahepatic portosystemic shunt in combination with oral anticoagulant for Budd-Chiari syndrome.
Seki S; Sakaguchi H; Kobayashi S; Kitada T; Nakamura K; Yamada R
Hepatogastroenterology; 2001; 48(41):1447-9. PubMed ID: 11677983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
